Bibliotecas PUC-SP - Busca Integrada

295 Tumor cell- intrinsic expression of FGFR3 drives anti-PDL-1 immunotherapy resistance in a murine bladder cancer model

Por Thomas Gajewski, Randy Sweis, Erica Fleming-Trujillo, Jeffrey Bloodworth, Anthony Fernald, Aubrianna Ramsland
Publicado no Journal for ImmunoTherapy of Cancer (2021-11-01)

642 Decreased host PKC-delta is associated with the T cell-inflamed tumor microenvironment and improves anti-tumor immunity

Por Thomas Gajewski, Ayelet Sivan, Keston Aquino-Michaels, Jessica Fessler, Randy Sweis, Emily Higgs, Kyle Cron, Seoho Lee
Publicado no Journal for ImmunoTherapy of Cancer (2021-11-01)

58 Excluding treg epitopes and integrating CD8 and CD4 effector neoepitope content improves prognostic biomarker tool in bladder cancer

Por Michael Princiotta, Arjun Balar, Gary Steinberg, Randy Sweis, Guilhem Richard, Tzintzuni Garcia, Matthew Ardito, William Martin, Gad Berdugo, Anne de Groot
Publicado no Journal for ImmunoTherapy of Cancer (2020-11-01)

756 First-in-human, open-label, multicenter, phase 1 clinical study to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of anti Siglec-15 PYX-106 in subjects wi...

Por Bin Zhang, Marsha Crochiere, Anthony W Tolcher, Randy Sweis, Kartik Sehgal, Michael S Gordon, Shui He, Jason Henry, Alexander I Spira, Shiraj Sen, Sandip P Patel, Sondra Smyrnios, Dipali Unadkat
Publicado no Journal for ImmunoTherapy of Cancer (2023-11-01)

771 A phase 1 study to assess safety, efficacy, pharmacokinetics, and pharmacodynamics of intratumoral CLN-617 (IL2/IL12 fusion protein) combined with pembrolizumab in patients wit...

Por Evan Hall, Adi Diab, Sajeve Thomas, Randy Sweis, Anthony El-Khoueiry, Naveen K Mehta, Jennifer S Michaelson, Laura Liu, Reham Abdel-Wahab, Jeffrey A Jones, Kaida Wu, Benjamin S Maciejewski
Publicado no Journal for ImmunoTherapy of Cancer (2023-11-01)

666 Safety, efficacy, and biomarker results of SRK-181, a latent TGFβ1 inhibitor, in anti-PD-1 resistant metastatic ccRCC patients

Por Minal Barve, Ahmad A Tarhini, Deepak Kilari, Rana Mckay, Randy Sweis, Timothy Yap, Justin Gainor, Raghad Karim, Lu Gan, Lan Liu, David Park, Ulka N Vaishampayan, Amna Sher, Sunil Babu, Yawen Ju, Susan Henry
Publicado no Journal for ImmunoTherapy of Cancer (2023-11-01)

726 Establishing proof of mechanism in patients: preliminary biomarker data of SRK-181 (a latent TGFβ1 inhibitor) from DRAGON Study

Por Minal Barve, Ahmad A Tarhini, Deepak Kilari, Randy Sweis, Timothy Yap, John Clark, Justin Gainor, Lu Gan, Ulka N Vaishampayan, Amna Sher, Yawen Ju, Susan Henry, Stephen DeWall, Asia McCune, Mo Qatanani
Publicado no Journal for ImmunoTherapy of Cancer (2023-11-01)